Yuichiro Ii Selected Research

Yuichiro Ii Research Topics

Disease

3	Myasthenia Gravis 06/2020 - 01/2013
3	Neoplasms (Cancer) 06/2020 - 01/2009
2	Atrial Fibrillation 01/2022 - 01/2021
2	Dementia (Dementias) 01/2021 - 01/2017
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2021 - 01/2017
2	Parkinsonian Disorders (Parkinsonism) 01/2021 - 01/2020
2	Inflammation (Inflammations) 01/2021 - 03/2015
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2017
2	Thymoma (Thymic Carcinoma) 10/2017 - 01/2013
2	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 03/2015
2	Thrombophilia 04/2014 - 03/2012
1	Cerebellar Ataxia (Dysmetria) 12/2021
1	Disease Progression 12/2021
1	Intracranial Embolism 01/2021
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2021
1	Siderosis 01/2021
1	Proteinuria 06/2020
1	Diplopia (Double Vision) 06/2020
1	Virus Diseases (Viral Diseases) 06/2020
1	Multiple Myeloma 06/2020
1	Prodromal Symptoms 01/2020
1	Necrosis 01/2020
1	Arteriolosclerosis 01/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 05/2019
1	Embolism (Embolus) 01/2019
1	Cognitive Dysfunction 01/2018
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2017
1	Vasculitis (Vasculitides) 03/2015
1	Venous Thrombosis (Deep-Vein Thrombosis) 04/2014
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 03/2012
1	Thrombosis (Thrombus) 01/2012
1	Meningitis 03/2009
1	Encephalitis (Encephalitis, Rasmussen) 01/2009
1	Ovarian Teratoma 01/2009
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 10/2007
1	Hashimoto's encephalitis 10/2007
1	Hashimoto Disease (Thyroiditis, Hashimoto) 10/2007
1	Hypothyroidism 10/2007
1	Leukocytosis (Pleocytosis) 10/2007

Drug/Important Bio-Agent (IBA)

4	AutoantibodiesIBA 12/2021 - 10/2007
3	Proteins (Proteins, Gene)FDA Link 12/2021 - 10/2017
3	AntibodiesIBA 06/2020 - 10/2007
3	Protein SIBA 04/2014 - 01/2012
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2020
2	Cholinergic ReceptorsIBA 06/2020 - 10/2017
2	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 06/2020 - 01/2013
2	Amyloid beta-PeptidesIBA 01/2020 - 03/2015
2	Amyloid (Amyloid Fibrils)IBA 01/2017 - 03/2015
2	Protein CIBA 04/2014 - 03/2012
2	AntithrombinsIBA 04/2014 - 03/2012
1	PeroxiredoxinsIBA 01/2021
1	neuromelaninIBA 01/2021
1	IronIBA 01/2021
1	Glial Fibrillary Acidic ProteinIBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2020
1	Thalidomide (Thalomid)FDA Link 06/2020
1	Bortezomib (Velcade)FDA Link 06/2020
1	muskIBA 06/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2020
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2020
1	Antipsychotic Agents (Antipsychotics)IBA 01/2020
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2020
1	PyrinIBA 05/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	LDL Receptors (LDL Receptor)IBA 10/2017
1	Formaldehyde (Formol)FDA Link 01/2017
1	Biomarkers (Surrogate Marker)IBA 03/2015
1	Prednisolone (Predate)FDA LinkGeneric 01/2013
1	protein S TokushimaIBA 01/2012
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2009
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2009
1	Glucose (Dextrose)FDA LinkGeneric 10/2007
1	NR2B NMDA receptorIBA 10/2007
1	Methylprednisolone FDA LinkGeneric 10/2007
1	DNA (Deoxyribonucleic Acid)IBA 10/2007
1	Ionotropic Glutamate ReceptorsIBA 10/2007
1	Thyroglobulin FDA Link 10/2007

Therapy/Procedure

3	Therapeutics 01/2022 - 03/2015
1	Immunotherapy 12/2021
1	Catheter Ablation 01/2021
1	Drug Therapy (Chemotherapy) 06/2020
1	Activities of Daily Living (ADL) 01/2018